Reverse transcription of human immunodeficiency virus type 1 is blocked by retroviral zinc finger inhibitors

Antiviral Chemistry and Chemotherapy

Volumn 8, Issue 1, 1997, Pages 60-69

  Turpin, J A ^a   Schaeffer, C A ^a   Terpening, S J ^a   Graham, L ^a   Bu, M ^a   Rice, W G ^a  

^a SAIC FREDERICK INC   (United States)

Author keywords

Antivirals; Cross linkage; DIBAs; HIV 1; Nucleocapsid protein; Reverse transcription

Indexed keywords

2,2' DITHIOBIS(BENZAMIDE) DERIVATIVE; ANTIVIRUS AGENT; BENZAMIDE DERIVATIVE; COSALANE; DEXTRAN SULFATE; PROTEIN INHIBITOR; UC 38; UNCLASSIFIED DRUG; VIRUS PROTEIN; ZALCITABINE; ZIDOVUDINE; ZINC FINGER PROTEIN;

ARTICLE; CELL CULTURE; CHEMICAL MODIFICATION; CONTROLLED STUDY; CROSS LINKING; DNA SYNTHESIS; DRUG MECHANISM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROTEIN MODIFICATION; RETROVIRUS; REVERSE TRANSCRIPTION; VIRION; VIRUS REPLICATION;

EID: 0031024735     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632029700800107     Document Type: Article

References (37)

1. Aldovini A & Young RA (1990) Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of non infectious virus. Journal of Virology 67:1920-1926.
2. Bader JP, McMahon JB, Schultz RJ, Narayanan VL, Pierce JB, Harrison WA, Weislow OS, Midelfort CF, Stinson SF & Boyd MR (1991) Oxathiin carboxanilide, a potent inhibitor of human immunodeficiency virus reproduction. Proceedings of the National Academy of Sciences, USA 88:6740-6744.
3. Berg JM (1986) Potential metal-binding domains in nucleic acid binding proteins. Science 232:485-487.
4. Cameron P, Pope M, Granelli-Piperno A & Steinman RM (1996) Dendritic cells and the replication of HIV-1. Leukocyte Biology 59:158-171.
5. Covey SN (1986) Amino acid sequence homology in gag region of reverse transcribing elements and the coat protein gene of cauliflower mosaic virus. Nucleic Acids Research 14:623-633.
6. Cushman M, Golebiewski WM, McMahon JB, Buckheit RW, Jr Clanton DJ, Weislow O, Haugwitz RD, Bader JP, Graham L & Rice WG (1994) Design, synthesis and biological evaluation of cosalane, a novel anti-HIV agent which inhibits multiple features of virus reproduction. Journal of Medicinal Chemistry 37:3040-3050.
7. Darlix J-L, Vincent A, Gabus C, De Rocquigny H & Roques B (1993) Trans-activation of the 5′ to 3′ viral DNA strand transfer by nucleocapsid protein during reverse transcription of HIV-1 RNA. Comptes Rendus de l'Academie des Sciences Serie III 316:763-771.
8. 23-→ Cys mutant nucleocapsid protein of HIV-1 indicate that the conformation of the first zinc finger is critical for virus infectivity. Biochemistry 33:11707-11716.
9. De Rocquigny H, Gabus C, Vincent A, Fournié-Zaluski M-C, Roques B & Darlix J-L (1992) Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers. Proceedings of the National Academy of Sciences, USA 89:6472-6476.
10. Dorfman T, Luban J, Goff SP, Haseltine WA & Göttlinger HG (1993) Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein. Journal of Virology 67:6159-6169.
11. Dupraz P, Oertle S, Meric C, Damay P & Spahr P-F (1990) Point mutations in the proximal Cys-His box of Rous Sarcoma virus nucleocapsid protein. Journal of Virology 64:4978-4987.
12. Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz K & Haase AT (1993) Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation of AIDS. Nature 362:359-362.
13. gag virus-like particles from recombinant baculovirus-infected insect cells. Cell 59:103-112.
14. Gorelick RJ, Nigida SM Jr, Bess JW Jr, Arthur LO, Henderson LE & Rein A (1990) Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. Journal of Virology 64:3207-3211.
15. Gorelick RJ, Chabot DJ, Rein A, Henderson LE & Arthur LO (1993) The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent. Journal of Virology 67:4027-4036.
16. Gorelick RJ, Chabot DJ, Ott DE, Gagliardi TD, Rein A, Henderson LE & Arthur LO (1996) Genetic analysis of the zinc finger in the Moloney murine leukemia virus nucleocapsid domain: replacement of zinc-coordinating residues with other zinc-coordinating residues yields noninfectious particles containing genomic RNA. Journal of Virology 70:2593-2597.
17. 4-Cys peptide binds metal ions: spectroscopic studies and a proposed three-dimensional structure. Proceedings of the National Academy of Sciences, USA 86:4047-4051.
18. Heath SL, Tew JG, Szakal AK & Burton GF (1995) Follicular dendritic cells and human immunodeficiency virus infectivity. Nature 377:740-744.
19. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM & Markowitz M (1995) Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126.
20. Lapadat-Tapolsky M, De Rocquigny H, Van Gent D, Roques B, Plasterk R & Darlix J-L (1993) Interactions between HIV-1 nucleocapsid protein and viral DNA may have important functions in the viral life cycle. Nucleic Acids Research 21:831-839.
21. Lys in vitro: studies of viral RNA molecules mutated in regions that flank the primer binding site. Journal of Virology 70:4996-5004.
22. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP & Fauci AS (1993) HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362:355-358.
23. Rice WG, Schaeffer CA, Graham L, Bu M, McDougal J, Orloff SL, Villinger F, Young M, Oroszlan S, Fesen MR, Pommier Y, Mendeleyev J & Kun E (1993a) The site of action of 3-nitrosobenzamide on the infectivity process of human immunodeficiency virus in human lymphocytes. Proceedings of the National Academy of Sciences, USA 90:9721-9724.
24. Rice WG, Schaeffer CA, Harten B, Villinger F, South TL, Summers MF, Henderson LE, Bess JW, Jr Arthur LO, McDougal JS, Orloff SL, Mendeleyev J & Kun E (1993b) Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds. Nature 361:473-475.
25. Rice WG Supko JG, Malspeis L, Buckheit RW Jr, Clanton D, Bu M, Graham L, Schaeffer CA, Turpin JA, Domagala J, Gogliotti R, Bader JP, Halliday SM, Coren L, Sowder RC II, Arthur LO & Henderson LE (1995a) Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS. Science 270:1194-1197.
26. Rice WG, Turpin JA, Arthur LO & Henderson LE (1995b) Highly conserved retroviral zinc fingers as targets for HIV-1 therapeutic management. International Antiviral News 3:87-89.
27. Rice WG, Arthur LO, Henderson LE & Turpin JA (1996) Discovery and development of disulfide-substituted benzamides as candidate anti-HIV drugs. International Antiviral News 4:3-6.
28. Rice WG, Baker D, Schaeffer CA, Graham L, Bu M, Terpening S, Clanton D, Henderson LE, Schultz R, Bader JP, Buckheit RW Jr, Field L, Singh PK & Turpin JA (1997) Inhibition of multiple phases of HIV-1 replication by a dithiane compound that attacks the conserved zinc fingers of retroviral nucleocapsid proteins. Antimicrobial Agents and Chemotherapy (in press).
29. Rodriguez-Rodriguez L, Tsuchihashi Z, Fuentes GM, Bambara RA & Fay PJ (1995) Influence of human immunodeficiency virus nucleocapsid protein on synthesis and strand transfer by the reverse transcriptase in vitro. Journal of Biological Chemistry 270:15005-15011.
30. Tanchou V, Gabus C, Rogemond V & Darlix J-L (1995) Formation of stable and functional HIV-1 nucleoprotein complexes in vitro. Journal of Molecular Biology 252:563-571.
31. Trono D (1992) Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses. Journal of Virology 66:4893-4900.
32. Turpin JA, Terpening SJ, Schaeffer CA, Yu G, Glover CJ, Felsted RL, Sausville EA & Rice WG (1996) Inhibitors of HIV-1 zinc fingers prevent normal processing of Gag precursors and result in the release of noninfectious virus particles. Journal of Virology 70:6180-6189.
33. Wei X Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BA, Saag MS & Shaw GM (1995) Viral dynamics in human immunodeficiency virus type I infection. Nature 373:117-122.
34. Xiaodong J, Klarmann GJ & Preston BD (1996) Effect of human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein on HIV-1 reverse transcriptase activity in vitro. Biochemistry 35:132-143.
35. You JC & McHenery CS (1994) Human immunodeficiency virus nucleocapsid protein accelerates strand transfer of the terminally redundant sequences involved in reverse transcription. Journal of Biological Chemistry 269:31491-31495.
36. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A & Chen SY (1990) HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213-222.
37. Zhang H, Zhang Y, Spicer TP, Abbott LZ, Abott M & Poiesz BJ (1993) Reverse transcription takes place within extracellular HIV-1 virions: potential biological significance. AIDS Research and Human Retroviruses 9:1287-1296.